Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

High frequency of anti-DSG 2 antibodies in post COVID-19 serum samples.

Authors:
Edward C Y Lee Ryan E Tyler Derrick Johnson Natalie Koh Biauw Chi Ong Shi Yin Foo Jack W C Tan

J Mol Cell Cardiol 2022 Jun 25;170:121-123. Epub 2022 Jun 25.

National Heart Centre, Singapore; Sengkang General Hospital, Singapore.

Background: There is growing recognition that COVID-19 does cause cardiac sequelae. The underlying mechanisms involved are still poorly understood to date. Viral infections, including COVID-19, have been hypothesized to contribute to autoimmunity, by exposing previously hidden cryptic epitopes on damaged cells to an activated immune system. Given the high incidence of cardiac involvement seen in COVID-19, our aim was to determine the frequency of anti-DSG2 antibodies in a population of post COVID-19 patients.

Methods And Results: 300 convalescent serum samples were obtained from a group of post COVID-19 infected patients from October 2020 to February 2021. 154 samples were drawn 6 months post-COVID-19 infection and 146 samples were drawn 9 months post COVID infection. 17 samples were obtained from the same patient at the 6- and 9- month mark. An electrochemiluminescent-based immunoassay utilizing the extracellular domain of DSG2 for antibody capture was used. The mean signal intensity of anti-DSG2 antibodies in the post COVID-19 samples was significantly higher than that of a healthy control population (19 ± 83.2 in the post-COVID-19 sample vs. 2.1 ± 7.2 (p < 0. 0001) in the negative control healthy population). Of note, 29.3% of the post COVID-19 infection samples demonstrated a signal higher than the 90th percentile of the control population and 8.7% were higher than the median found in ARVC patients. The signal intensity between the 6-month and 9-month samples did not differ significantly.

Conclusions: We report for the first time that recovered COVID-19 patients demonstrate significantly higher and sustained levels of anti-DSG2 autoantibodies as compared to a healthy control population, comparable to that of a diagnosed ARVC group.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yjmcc.2022.06.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9233549PMC
June 2022

Publication Analysis

Top Keywords

post covid-19
16
samples drawn
8
antibodies post
8
serum samples
8
anti-dsg2 antibodies
8
covid-19
7
samples
6
post
5
involvement covid-19
4
9 months post
4
146 samples
4
cardiac involvement
4
drawn 9 months
4
covid-19 aim
4
incidence cardiac
4
high incidence
4
21 ± 72 p 
4
activated immune
4
system high
4
immune system
4

Keyword Occurance

Similar Publications

Incidence and Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 Infection After Vaccination in Children.

Authors:
Megan E Reyna Priya R Edward Egon A Ozer Lacy M Simons Judd F Hultquist Ramon Lorenzo-Redondo Ami B Patel Larry K Kociolek

J Pediatr 2022 Aug 9. Epub 2022 Aug 9.

Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL 60611, USA; Division of Infectious Diseases, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA. Electronic address:

The objective of this single-center cohort study was to characterize frequency, clinical characteristics, and molecular epidemiology of pediatric SARS-CoV-2 infection after vaccination. Between 5/15/2021 and 1/1/2022, 171 children experienced SARS-CoV-2 infection post-vaccination, 146 (86%) following Omicron variant predominance. Outcomes were generally mild and comparable before and after Omicron predominance. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Early Change in Lower Limb Strength and Function in Lung Transplant Patients After Center-Based and Telerehabilitation.

Authors:
Lisa Wickerson Dmitry Rozenberg Lianne G Singer Sunita Mathur

J Cardiopulm Rehabil Prev 2022 Aug 11. Epub 2022 Aug 11.

Toronto Lung Transplant Program, University Health Network, Toronto, Canada (Drs Wickerson, Rozenberg, and Singer); Departments of Physical Therapy (Wickerson) and Medicine (Drs Rozenberg and Singer), University of Toronto, Toronto, Canada; and School of Rehabilitation Therapy, Queen's University, Kingston, Canada (Dr Mathur).

Purpose: The aim of this study was to examine the change and relationship among quadriceps torque (QT) and physical function in adult lung transplant (LTx) patients undergoing rehabilitation.

Methods: A prospective study assessed 6-min walk test (6MWT) distance, QT, and Short Physical Performance Battery (SPPB) at the start of pre-habilitation and 10-12 wk post-LTx. Functional outcomes were examined for within-group differences for participants who completed center-based rehabilitation between September 2019 and March 2020 and participants who completed telerehabilitation ("telerehab") between March 2020 and June 2021 during COVID-19. Read More

View Article and Full-Text PDF
August 2022
Similar Publications

Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study.

Authors:
Murray Dryden Caroline Mudara Caroline Vika Lucille Blumberg Natalie Mayet Cheryl Cohen Stefano Tempia Arifa Parker Jeremy Nel Rubeshan Perumal Michelle J Groome Francesca Conradie Norbert Ndjeka Louise Sigfrid Laura Merson Waasila Jassat

Lancet Glob Health 2022 Sep;10(9):e1247-e1256

Division of Public Health Surveillance and Response, National Institute for Communicable Diseases, Division of the National Health Laboratory Services, Johannesburg, South Africa; Right to Care, Centurion, South Africa.

Background: Post COVID-19 condition (PCC), as defined by WHO, refers to a wide range of new, returning, or ongoing health problems in people who have had COVID-19, and it represents a rapidly emerging public health priority. We aimed to establish how this developing condition has affected patients in South Africa and which population groups are at risk.

Methods: In this prospective cohort study, we used the DATCOV national hospital surveillance system to identify participants aged 18 years or older who had been hospitalised with laboratory-confirmed SARS-CoV-2 infection in South Africa. Read More

View Article and Full-Text PDF
September 2022
Similar Publications

Post-COVID-19 condition: current evidence and unanswered questions.

Authors:
Olufemi Erinoso

Lancet Glob Health 2022 Sep;10(9):e1210-e1211

National Postgraduate Medical College, Nigeria; Department of Social and Behavioral Health, School of Public Health, University of Nevada, Reno, Reno, NV 89557, USA. Electronic address:

View Article and Full-Text PDF
September 2022
Similar Publications

Immunodeficiency syndromes differentially impact the functional profile of SARS-CoV-2-specific T cells elicited by mRNA vaccination.

Authors:
Yu Gao Curtis Cai David Wullimann Julia Niessl Olga Rivera-Ballesteros Puran Chen Joshua Lange Angelica Cuapio Ola Blennow Lotta Hansson Stephan Mielke Piotr Nowak Jan Vesterbacka Mira Akber Andre Perez-Potti Takuya Sekine Thomas R Müller Caroline Boulouis Tobias Kammann Tiphaine Parrot Jagadeeswara Rao Muvva Michal Sobkowiak Katie Healy Gordana Bogdanovic Sandra Muschiol Gunnar Söderdahl Anders Österborg Fredrika Hellgren Alba Grifoni Daniela Weiskopf

Immunity 2022 Jul 19. Epub 2022 Jul 19.

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.

Many immunocompromised patients mount suboptimal humoral immunity after SARS-CoV-2 mRNA vaccination. Here, we assessed the single-cell profile of SARS-CoV-2-specific T cells post-mRNA vaccination in healthy individuals and patients with various forms of immunodeficiencies. Impaired vaccine-induced cell-mediated immunity was observed in many immunocompromised patients, particularly in solid-organ transplant and chronic lymphocytic leukemia patients. Read More

View Article and Full-Text PDF
July 2022
Similar Publications
}
© 2022 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap